Return to Vaccination News Home Page
Subscribe to the Vaccination NewsLetter
View past & current Scandals (columns by Sandy Mintz)
Search This Site using keywords
Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
———————————————————————
June 06, 2003
U.S. IMMUNIZATION NEWS
“Avant Achieves Milestones in Anthrax Vaccine Development”
Dow Jones Newswire (www.wsj.com) (06/05/03)
Avant Immunotherapies has received two additional subcontracts for vaccine development. One of the subcontracts is for $344,000, for stability testing of DynPort's injectable anthrax vaccine, while the other subcontract is for $1.3 million, to begin pre-clinical animal testing of Avant's oral vaccine against anthrax and plague. Testing of DynPort's anthrax vaccine will begin the first phase in October.
Return to Vaccination News Home Page
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.